Please assess the completion status of the following clinical trial:

Trial Title: Dysport® Adult Lower Limb Spasticity Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects aged 18 to 80 years of age~* Post stroke or brain injury~* Intensity of muscle tone greater than or equal to 2, as measured on the Modified Ashworth Scale~* Ambulatory patients~Exclusion Criteria:~* Fixed contractures~* Physiotherapy initiated less than 4 weeks before entry~* Previous surgery or previous treatment with phenol and/or alcohol in lower limb~* Neurological/neuromuscular disorders which may interfere with protocol evaluations

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Dysport® 1000 U, IM (Type: EXPERIMENTAL): 1000 U, I.M. (in the muscle), on day 1 (single treatment cycle)
- Dysport® 1500 U, IM (Type: EXPERIMENTAL): 1500 U, I.M., on day 1 (single treatment cycle)
- Placebo (Type: PLACEBO_COMPARATOR): I.M., on day 1 (single treatment cycle)

Based on this trial design, predict the completion outcome and termination type (if applicable).